Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

MT Long, S Gandhi, R Loomba - Metabolism, 2020 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …
被引用次数：64 相关文章

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

MT Long, S Gandhi, R Loomba - Metabolism-Clinical and …, 2020 - metabolismjournal.com
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …
[HTML] nih.gov

[HTML][HTML] Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

MT Long, S Gandhi, R Loomba - Metabolism: clinical and …, 2020 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

MT Long, S Gandhi, R Loomba - Metabolism: clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

MT Long, S Gandhi, R Loomba - Metabolism: Clinical and …, 2020 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

MT Long, S Gandhi, R Loomba - Metabolism, 2020 - hero.epa.gov
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

M Long, S Gandhi, R Loomba - 2020 - escholarship.org
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …

Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.

MT Long, S Gandhi, R Loomba - 2020 - escholarship.org
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in
the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum …